ArticleIranian journal of pharmaceutical research : IJPR2018

Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines.

Niki Vakili Zahir et al.PubMed ↗Full text ↗

No numbers read from the abstract.